Trajan with University of Adelaide named finalist for Excellence in Research Collaboration award
Trajan Scientific and Medical (Trajan) together with the University of Adelaide's Institute for Photonics and Advanced Sensing (IPAS) are honored to be named as a finalist for the Excellence in Research Collaboration award by the Government of South Australia.
From the Government of South Australia, Department of State Development:
The Science Excellence Awards is South Australia’s premier event to recognise and reward outstanding scientific endeavour, including its application in industry and the advancement of science and mathematics education.
Finalist for the 2016 South Australian Science Excellence Award - Excellence in Research Collaboration:
-
Trajan - University of Adelaide partnership
In November 2015, the University of Adelaide (UoA) commenced a major strategic partnership with Trajan Scientific and Medical (Trajan), with the support of the South Australian government, and launched the new Trajan R&D and Manufacturing Hub in Adelaide at the University. This collaboration is enabling the realisation of research, development and commercialisation of new generation specialty glass products for the global science and medical equipment market.
Book tickets to the 2016 SA Science Excellence Awards long luncheon to be held on 12 August 2016 at the Adelaide Convention Centre, South Australia.
Photo (L-R): Professor Mike Brooks, Deputy Vice-Chancellor (Research), University of Adelaide and Mr Stephen Tomisich, Chief Executive Officer, Trajan Scientific and Medical.
More information
2016 Science Excellence Awards SA
University’s partnership proves Agenda’s strengths
Trajan announces landmark collaboration in R&D and manufacturing with Australian academia and government
Media contact information
Trajan Scientific and Medical
media@trajanscimed.com
+44 (0) 1244 403 100
 together with the University of Adelaide's Institute for Photonics and Advanced Sensing (IPAS) are honored to be named as a finalist for the Excellence in Research Collaboration award by the Governm...&media=//cdn.shopify.com/s/files/1/0767/9441/articles/TrajanUoAIPASSAGov3_600x.jpg?v=1470135956){kind=link}
Also in News
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
European patent for Trajan’s hemaPEN
US FDA listing of Trajan’s hemaPEN blood microsampling device
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.